Carbamazepine is an inhibitor of histone deacetylases
- 13 May 2005
- journal article
- Published by Elsevier BV in Life Sciences
- Vol. 76 (26), 3107-3115
- https://doi.org/10.1016/j.lfs.2005.01.003
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Activity of Antiepileptic Drugs as Histone Deacetylase InhibitorsEpilepsia, 2004
- Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824Cancer Research, 2004
- Update on new developments in the study of human teratogensTeratology, 2002
- Transcriptional Repression of the Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mediated by CCAAT Displacement Protein/cut Homolog, Is Associated with Histone DeacetylationPublished by Elsevier BV ,1999
- Differential Expression of Human Histone Deacetylase mRNAs in Response to Immune Cell Apoptosis Induction by Trichostatin A and ButyrateBiochemical and Biophysical Research Communications, 1998
- Carbamazepine-induced lymphadenopathy mimicking Ki-1 (CD30 +) T-cell lymphomaPathology, 1997
- Segregation of the growth slowing effects of valproic acid from phenytoin and carbamazepine on lymphoid tumor cellsLife Sciences, 1992
- Development of Aqueous Parenteral Formulations for Carbamazepine through the Use of Modified CyclodextrinsJournal of Pharmaceutical Sciences, 1991
- Pattern of Malformations in the Children of Women Treated with Carbamazepine during PregnancyNew England Journal of Medicine, 1989
- Pseudo-lymphoma associated with carbamazepineClinical and Experimental Dermatology, 1984